Herwig Koppensteiner

2.2k citations

25 papers · 1.0k indexed · h-index 16

Impact in

Virology top 1%
- HIV Research and Treatment
Immunology top 10%
- Immune Cell Function and Interaction

Papers in

Virology 12
- HIV Research and Treatment 12
Immunology 9
- Immune Cell Function and Interaction 8

Co-authors: Michael Schindler Ruth Brack‐Werner Carina Banning Frank Kirchhoff Stephanie Rebensburg Markus Helfer Martha Schneider Sebastian Dörn
Journals: Retrovirology (3 papers)Journal of Virology (3 papers)PLoS ONE (3 papers)Blood (2 papers)British Journal of Dermatology (2 papers)
Partner nations: Germany United States Austria

In The Last Decade

Herwig Koppensteiner

22 papers receiving 999 citations

Peers

Countries citing papers authored by Herwig Koppensteiner

Since Specialization

Citations

This map shows the geographic impact of Herwig Koppensteiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herwig Koppensteiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herwig Koppensteiner more than expected).

Fields of papers citing papers by Herwig Koppensteiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herwig Koppensteiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herwig Koppensteiner. The network helps show where Herwig Koppensteiner may publish in the future.

Co-authors

The 25 scholars most cited alongside Herwig Koppensteiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Herwig Koppensteiner Line = papers co-authored together Herwig Koppensteiner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis Allergy ·Amy S. Paller, Lawrence F. Eichenfield, Alan D. Irvine, Carsten Flohr, Andreas Wollenberg, S. Barbarot, Christine Bangert, Jonathan M. Spergel, Andrew Selfridge, Peter C Lutkin, Haiyun Fan, Jean-Phillippe Proulx-Gauthier, Emory R. Johnson, Herwig Koppensteiner	2025	0
2	P81 Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND British Journal of Dermatology ·Amy S. Paller, Michael J. Cork, Carsten Flohr, Christine Bangert, Stephan Weidinger, Philipp Hansen, 石与丹, Pinaki Biswas, Emory R. Johnson, Herwig Koppensteiner	2023	1
3	44042 Abrocitinib Long-Term Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study Journal of the American Academy of Dermatology ·Kristian Reich, Jonathan I. Silverberg, Marjolein de Bruin‐Weller, Mette Deleuran, Lisa A. Beck, Kim Papp, 石与丹, Fan Zhang, Claire Feeney, Herwig Koppensteiner	2023	1
4	Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors Molecular Therapy — Methods & Clinical Development ·Кирило Олександрович Терещенко, V. A. Malahovich, Bettina Hartlieb, Sebastian Dörn, Herwig Koppensteiner, Frank Horling, Friedrich Scheiflinger, Birgit M. Reipert, Maurus de la Rosa	2019	137
5	Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays Human Gene Therapy Methods ·Кирило Олександрович Терещенко, Herwig Koppensteiner, V. A. Malahovich, Bettina Hartlieb, Sebastian Dörn, 仁宏和田, 恵逸斎藤, Alfred Weber, 나효진, Frank Horling, Friedrich Scheiflinger, Birgit M. Reipert, Maurus de la Rosa	2019	25
6	T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients Journal of the International AIDS Society ·Denis Bensoussan, Herwig Koppensteiner, Ramona Businger, Stephanie Rebensburg, M.C.S. Shathifa, Ruth Brack‐Werner, Rika Draenert, Michael Schindler	2017	7
7	Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection Open Biology ·Kristin Höhne, Ramona Businger, Anouk Van Nuffel, Denis Bensoussan, Herwig Koppensteiner, Oludaisi Adeshina Oduniyi, Jolien Vermeíre, Eva Malatinková, Bruno Verhasselt, Michael Schindler	2016	23
8	Anti-Pegaspargase, Anti-Calaspargase Pegol , and Anti-Polyethelene Glycol Antibody Incidence in High Risk Acute Lymphoblastic Leukemia Patients Receiving Pegaspargase or Calaspargase Pegol and Associated Anaphylactic or Hypersensitivity Reaction Rates: Results from Children's Oncology Group (COG) Study AALL07P4 Blood ·Reuven J. Schore, Meenakshi Devidas, Archie Bleyer, Gregory H. Reaman, Claudia Lebedinsky, Hui Zhang, Herwig Koppensteiner, Mignon L. Loh, Elizabeth A. Raetz, Naomi Winick, William L. Carroll, Stephen P. Hunger, Anne Angiolillo	2016	4
9	Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins Scientific Reports ·Stephanie Rebensburg, Markus Helfer, Martha Schneider, Herwig Koppensteiner, Josef Eberle, Michael Schindler, Lutz Gürtler, Ruth Brack‐Werner	2016	73
10	A Combined Omics Approach to Generate the Surface Atlas of Human Naive CD4+ T Cells during Early T-Cell Receptor Activation Molecular & Cellular Proteomics ·Evelyn Newman, Stefanie M. Hauck, Christine von Toerne, Edda Kloppmann, Tatyana Goldberg, Herwig Koppensteiner, Michael Schindler, Bettina L. Knapp, Linda Krause, Appalanaidu Maheshvari, Carsten B. Schmidt‐Weber, Bhanu P. Valluri	2015	26
11	HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4⁺T Lymphocytes Journal of Virology ·Lia Vassena, Erica Giuliani, Herwig Koppensteiner, Denis Bensoussan, Michael Schindler, Margherita Doria	2015	36
12	The Root Extract of the Medicinal Plant Pelargonium sidoides Is a Potent HIV-1 Attachment Inhibitor PLoS ONE ·Markus Helfer, Herwig Koppensteiner, Martha Schneider, Stephanie Rebensburg, Sara Forcisi, Constanze Müller, Philippe Schmitt‐Kopplin, Michael Schindler, Ruth Brack‐Werner	2014	80
13	Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis Retrovirology ·Herwig Koppensteiner, Kristin Höhne, Marcos V. P. Gondim, François-Xavier Gobert, 汪贵平, Shakiba Kalantari, Anke Heigele, Frank Kirchhoff, Michael Winkler, Philippe Benaroch, Michael Schindler	2014	31
14	The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells Cancer Letters ·Annemarie Losert, Daniela Lötsch, Andreas Lackner, Herwig Koppensteiner, د مایسة محمد عفیفى السید, Elisabeth Steiner, Klaus Holzmann, Thomas W. Grunt, Katharina Schmid, Brigitte Marian, Bettina Grasl‐Kraupp, Rolf Schulte‐Hermann, Georg Krupitza, Walter Berger, Michael Grusch	2012	29
15	Macrophages and their relevance in Human Immunodeficiency Virus Type I infection Retrovirology ·Herwig Koppensteiner, Ruth Brack‐Werner, Michael Schindler	2012	203
16	Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317 Virology ·Denis Bensoussan, Jörg Votteler, Beatriz da Silva Rosa Bagatini, Timo Greiner, Herwig Koppensteiner, Michael Schindler, Gerhard Thiel, Ulrich S. Schubert	2011	32
17	Macrophage Internal HIV-1 Is Protected from Neutralizing Antibodies Journal of Virology ·Herwig Koppensteiner, Carina Banning, Carola Schneider, Heinrich Hohenberg, Michael Schindler	2011	66
18	A Flow Cytometry-Based FRET Assay to Identify and Analyse Protein-Protein Interactions in Living Cells PLoS ONE ·Carina Banning, Jörg Votteler, Dirk Hoffmann, Herwig Koppensteiner, Martin Warmer, Rudolph Reimer, Frank Kirchhoff, Ulrich S. Schubert, Joachim Hauber, Michael Schindler	2010	122
19	Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue Retrovirology ·Michael Schindler, Devi Rajan, Carina Banning, Peter Wimmer, Herwig Koppensteiner, DU Li-jun, Anke Specht, Daniel Sauter, Thomas Dobner, Frank Kirchhoff	2010	68
20	A bicistronic baculovirus vector for transient and stable protein expression in mammalian cells Analytical Biochemistry ·Andreas Lackner, Chancellor N, Herwig Koppensteiner, Irene Herbacek, Klaus Holzmann, Sabine Spiegl‐Kreinecker, Walter Berger, Michael Grusch	2008	5

About Herwig Koppensteiner

Herwig Koppensteiner is a scholar working on Virology, Immunology, Dermatology, Immunology and Allergy and Hematology, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), Immune Cell Function and Interaction (8 papers), Cytomegalovirus and herpesvirus research (5 papers), Pharmaceutical studies and practices (4 papers), CAR-T cell therapy research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Dermatology and Skin Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Virology (440 citations), Immunology (278 citations), Infectious Diseases (218 citations), Genetics (173 citations) and Emergency Medicine (50 citations). Herwig Koppensteiner has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Michael Schindler, Ruth Brack‐Werner, Carina Banning, Frank Kirchhoff, Stephanie Rebensburg, Markus Helfer, Martha Schneider, Sebastian Dörn, Frank Horling and Maurus de la Rosa. Their work appears in journals such as Retrovirology, Journal of Virology, PLoS ONE, Blood and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact